Hilltelligence markHilltelligence
Senate119th Congress · 2nd Session· Apr 23, 2026

Roll Call 103

Amendment Rejected

On the Amendment S.Amdt. 5336 to S.Con.Res. 33 (No short title on file)

To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.

What this vote was on

The bill or resolution this roll call concerns is not linked in our record. The chamber usually publishes that detail within hours of the vote, and we check again on every sync for 21 days afterward.

View the official record ↗

Yea48Nay50Not voting2
Democrats
44 – 0
Republicans
2 – 50
Independents
2 – 0

Member-by-member (100)

Yea (48)

Nay (50)

Present (0)

None

Not voting (2)